Search
Patexia Research
Case number IPR2022-00517

Mylan Pharmaceuticals Inc. et al. v. Bayer Pharma AG et al. > Documents

Date Field Doc. No.PartyDescription
Apr 25, 2023 0 patent_own Patent Owner's Opposition to Mylan's Motion to Exclude Download
Feb 2, 2022 1 petitioner Petition for Inter Partes Review of U.S. Patent No. 10,828,310 Download
Feb 2, 2022 2 petitioner Petitioner Mylan Pharmaceuticals Inc. Power of Attorney Download
Feb 11, 2022 3 board Notice of Filing Date Accorded to Petition Download
Feb 18, 2022 4 patent_own Patent Owner's Power of Attorney Download
Feb 18, 2022 5 patent_own Patent Owner's Mandatory Notices Download
Mar 4, 2022 6 petitioner Mylan Pharmaceuticals Inc. Unopposed Motion for Pro Hac Vice Recognition Download
Apr 6, 2022 7 board ORDER Conditionally Granting Petitioners Motion for Admission Pro Hac Vice of Elham F. Steiner 37 C.F.R. sec 42.10 c Download
Apr 7, 2022 8 petitioner Mylan's Mandatory Change-of-Information Notices Download
Apr 7, 2022 9 petitioner Petitioner Mylan's Updated Exhibit List Download
May 5, 2022 10 patent_own Patent Owner's First Updated Mandatory Notices Download
May 11, 2022 11 patent_own Patent Owner Preliminary Response Download
May 24, 2022 12 petitioner Petitioner Mylan Updated Mandatory Notices Download
May 31, 2022 13 petitioner Mylan's Reply to Bayer's Preliminary Response Download
Jun 7, 2022 14 patent_own Patent Owner's Authorized Sur-Reply Download
Aug 9, 2022 15 board Download
Aug 9, 2022 16 board Order: SCHEDULING ORDER Download
Aug 23, 2022 17 patent_own Patent Owner's Objections to Evidence Download
Aug 23, 2022 18 petitioner Mylan Objections to Preliminary-Proceeding Exhibits Download
Aug 26, 2022 19 patent_own Notice of Joint Stipulation to Modify the Scheduling Order Download
Aug 26, 2022 20 patent_own Joint Statement Regarding Preferences for the Location of Oral Argument Download
Sep 1, 2022 21 petitioner Petitioner Mylan Updated Mandatory Notices Download
Sep 7, 2022 22 petitioner Petitioner Mylan's Updated Exhibit List Download
Sep 7, 2022 23 patent_own Patent Owner's Motion for Pro Hac Vice Admission of Alexander S. Zolan Download
Sep 7, 2022 24 patent_own Patent Owner's Motion for Pro Hac Vice Admission of Kathryn S. Kayali Download
Sep 7, 2022 25 patent_own Patent Owner's Second Updated Mandatory Notices Download
Sep 20, 2022 26 board Granting Patent Owners Motions for Pro Hac Vice Admission of Alexander S. Zolan and Kathryn S. Kayali 37 C.F.R. sec 42.10 Download
Sep 22, 2022 27 patent_own Patent Owner's Third Updated Mandatory Notices Download
Sep 23, 2022 28 petitioner Petitioner Mylan Updated Mandatory Notices Download
Sep 26, 2022 29 petitioner Petitioner Mylan Updated Exhibit List Download
Oct 6, 2022 30 patent_own Joint Notice of Stipulation Concerning Joinder Download
Oct 19, 2022 31 patent_own Patent Owner's Notice of Deposition of Dr. Randall M. Zusman, M.D. Download
Oct 19, 2022 32 board Institution decision and grant of joinder, IPR2022-01515 Download
Oct 19, 2022 33 board Institution decision and grant of joinder, IPR2022-01513 Download
Oct 31, 2022 34 patent_own Patent Owner's Objections to Evidence of Joinder Petitioner Teva Pharmaceuticals USA, Inc. Download
Oct 31, 2022 35 patent_own Patent Owner's Objections to Evidence of Joinder Petitioner InvaGen Pharmaceuticals, Inc. Download
Nov 15, 2022 36 patent_own Patent Owner's Response Download
Nov 22, 2022 37 petitioner Petitioner Mylan Objections to Response Exhibits Download
Dec 14, 2022 38 petitioner Mylan Pharmaceuticals Inc. Unopposed Motion for Pro Hac Vice Recognation Download
Dec 14, 2022 39 petitioner Mylan Updated Power of Attorney Download
Dec 14, 2022 40 petitioner Mylan Updated Mandatory Notices Download
Dec 22, 2022 41 board ORDER Granting Petitioners Motion for Pro Hac Vice Admission of Susannah M. L. Gagnon 37 C.F.R. sec 42.10 Download
Dec 30, 2022 42 petitioner Petitioner's Notice of Deposition of Jeffrey Weitz Download
Feb 1, 2023 43 petitioner Second Joint Stipulation to Modify Schedule Download
Feb 17, 2023 44 petitioner Mylan Reply Download
Feb 17, 2023 45 petitioner Mylan's Updated Exhibit List Download
Feb 17, 2023 46 petitioner Mylan's Updated Exhibit List Download
Feb 27, 2023 47 patent_own Patent Owner's Objections to Evidence Download
Feb 27, 2023 48 patent_own Patent Owner's Fourth Updated Mandatory Notices Download
Feb 27, 2023 49 patent_own Patent Owner's Notice of Deposition of Dr. Randall M. Zusman, M.D. Download
Mar 6, 2023 50 patent_own Third Joint Stipulation to Modify Schedule Download
Mar 8, 2023 51 board Order: Conduct of the Proceeding Download
Mar 9, 2023 52 petitioner Mylan Reply - CORRECTED Download
Mar 9, 2023 53 petitioner Petitioner's Updated Exhibit List Download
Mar 28, 2023 54 patent_own Patent Owner's Request for Oral Argument Download
Mar 28, 2023 55 petitioner Petitioner's Request for Oral Argument Download
Apr 4, 2023 56 patent_own Patent Owner Surreply Download
Apr 5, 2023 57 board ORDER Setting Oral Argument Download
Apr 14, 2023 58 patent_own Patent Owner's Fifth Updated Mandatory Notices Download
Apr 18, 2023 59 petitioner Download
Apr 18, 2023 60 petitioner Petitioner's Updated Exhibit List Download
Apr 25, 2023 61 patent_own Patent Owner's Opposition to Mylan's Motion to Exclude Download
May 2, 2023 62 petitioner Mylan Reply for Motion to Exclude Download
May 4, 2023 64 board LEAP Practitioner Request and Verification Form (Petitioner) Download
May 5, 2023 65 petitioner Petitioner's Demonstratives Download
May 5, 2023 66 patent_own Patent Owner's Demonstrative Exhibits Download
May 31, 2023 67 board Other: Hearing transcript Download
Jun 9, 2023 68 patent_own Patent Owner's Sixth Updated Mandatory Notices Download
Jun 26, 2023 69 patent_own Patent Owner's Seventh Updated Mandatory Notices Download
Jul 28, 2023 70 board Download
Sep 22, 2023 71 patent_own Patent Owner's Notice of Appeal Download
Feb 2, 2022 1001 petitioner U.S. Patent 10,828,310, Reducing the Risk of Cardiovascular Events (issued Nov. 10, 2020) Download
Feb 2, 2022 1002 petitioner Expert Declaration of Dr. Randall M. Zusman, M.D. Download
Feb 2, 2022 1003 petitioner Curriculum vitae of Dr. Randall M. Zusman, M.D. Download
Feb 2, 2022 1004 petitioner File History of U.S. Patent Application No. 16/264,032 (Part 1) Download
Feb 2, 2022 1004 petitioner File History of U.S. Patent Application No. 16/264,032 (Part 2) Download
Feb 2, 2022 1004 petitioner File History of U.S. Patent Application No. 16/264,032 (Part 3) Download
Feb 2, 2022 1005 petitioner Committee for Medicinal Products for Human Use, European Medicines Agency, Assessment Report, Xarelto, EMA/CHMP/794349/2012, Procedure No. EMEA/H/C/000944/X/00017, March 21, 2013 Download
Feb 2, 2022 1006 petitioner Foley, T. R., et al., Antithrombotic therapy in peripheral artery disease, VASCULAR MED., 21(2), 2016, 156-69 Download
Feb 2, 2022 1007 petitioner Plosker, G. L., Rivaroxaban: A Review of Its Use in Acute Coronary Syndromes, DRUGS, 74, 2014, 451-64 Download
Feb 2, 2022 1008 petitioner Amsterdam, E. A., et al., 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes, J. AM. COL. CARDIOL., 64(24), 2014, e139-228 Download
Feb 2, 2022 1009 petitioner Download
Feb 2, 2022 1010 petitioner U.S. Patent Publication No. 2004/0242660, Substituted Oxazolidinones for Combinatorial Therapy, published Dec. 2, 2004 to Straub et al. Download
Feb 2, 2022 1011 petitioner Barstow, C., et al., Acute Coronary Syndrome: Diagnostic Evaluation, AM. FAM. PHYS., 95(3), 2017, 170-77 Download
Feb 2, 2022 1012 petitioner Download
Feb 2, 2022 1013 petitioner Dressman, J. B., et al., Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Acetylsalicylic Acid, J. PHARM. SCI., 101(8), 2012, 2653-67 Download
Feb 2, 2022 1014 petitioner Mega, J. L., et al., Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial, LANCET, 374, 2009, 29-38 Download
Feb 2, 2022 1015 petitioner Mega, J. L., et al., Rivaroxaban in Patients with a Recent Acute Coronary Syndrome, N. ENG. J. MED., 366(1), 2012, 9-19 Download
Feb 2, 2022 1016 petitioner Download
Feb 2, 2022 1017 petitioner Deichmann, R. E., et al., Considerations for Stopping a Clinical Trial Early, OCHSNER J. 16(3), 2016, 197-98 Download
Feb 2, 2022 1018 petitioner Siegal, D. M., et al., Adexanet Alfa for the Reversal of Factor Xa Inhibitor Activity, N. ENG. J. MED., 373(25), 2015, 2413-24 Download
Feb 2, 2022 1019 petitioner European Medicines Agency, Xarelto, https://www.ema.europa.eu/en/medicines/human/EPAR/Xarelto (last accessed February 2, 2022) Download
Feb 2, 2022 1020 petitioner Sivolella, S., et al., Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants, ODONTOL., 103(3), 2015, 258-63 Download
Mar 4, 2022 1021 petitioner Declaration of Elham F. Steiner Download
Apr 7, 2022 1021 petitioner (Corrected) Declaration of Elham F. Steiner Download
Mar 4, 2022 1022 petitioner Biography of Ellie F. Steiner Download
Sep 26, 2022 1024 petitioner Transcript of Board Telephone Conference on September 21, 2022 Download
Dec 14, 2022 1025 petitioner Declaration of Susannah M.L. Gagnon Download
Dec 14, 2022 1026 petitioner Attorney Bio of Susannah Gagnon Download
Feb 17, 2023 1027 petitioner Connolly [COMPASS Patient Info] Download
Feb 17, 2023 1028 petitioner Ruff [Comparison of Efficacy & Safety of NOACs with Warfarin Download
Feb 17, 2023 1029 petitioner Weitz Publication [NOACs, Which One Should My Patient Use] Download
Feb 17, 2023 1030 petitioner Weitz Deposition 1-25-23 Download
Mar 9, 2023 1030 petitioner EX1030 - Weitz Deposition Jan. 25, 2023 Download
Feb 17, 2023 1031 petitioner Janssen Research and Development Briefing Document Download
Feb 17, 2023 1032 petitioner WeitzJI Braunwald Heart Disease Download
Feb 17, 2023 1033 petitioner Zannand 2012 Download
Feb 17, 2023 1034 petitioner Taylor 2004 Download
Feb 17, 2023 1035 petitioner McMurray 2014 Download
Feb 17, 2023 1036 petitioner Aggrenox Download
Feb 17, 2023 1037 petitioner Zusman Expert Declaration ISO Reply Download
Mar 9, 2023 1037 petitioner Corrected Declaration of Randall M. Zusman, M.D. ISO Mylan Reply Download
Feb 17, 2023 1038 petitioner Data Supplement to the 2016 AHA ACC Guideline Download
Mar 9, 2023 1040 petitioner Transcript of Conference Call with PTAB Mar. 7, 2023 Download
Apr 18, 2023 1041 petitioner EX1041-Resnik Download
May 11, 2022 2001 patent_own EX2001 - Produced Supplemental Examination Download
May 11, 2022 2002 patent_own EX2002 - Production Cover Letter Download
May 11, 2022 2003 patent_own EX2003 - Joint Initial Invalidity Contentions (Excerpt) Download
May 11, 2022 2004 patent_own EX2004 - Xarelto Oct 2017 Label Download
May 11, 2022 2005 patent_own EX2005 - Eikelboom et al. NEJM (2017) Download
May 11, 2022 2006 patent_own EX2006 - MDL Transfer Order Download
May 11, 2022 2007 patent_own EX2007 - Micro Labs Scheduling Order Download
May 11, 2022 2008 patent_own EX2008 - Lupin (MDL) Scheduling Order Download
May 11, 2022 2009 patent_own EX2009 - 2021.07.22 [01] COMPLAINT against Mylan Download
May 11, 2022 2010 patent_own EX2010 - Mylan's Brief Regarding Proposed Trial Date Download
May 11, 2022 2011 patent_own EX2011 - Bayer's Brief Regarding Proposed Trial Date Download
May 11, 2022 2012 patent_own EX2012 - Mylan NDWV Docket Download
May 11, 2022 2013 patent_own EX2013 - NOS of Initial Infringement Charts Download
May 11, 2022 2014 patent_own EX2014 - Order Adopting Lupin Schedule in MDL Download
May 11, 2022 2015 patent_own EX2015 - Mylan's Non-Opposition to Motion to Transfer. Download
May 11, 2022 2016 patent_own EX2016 - NOS of Defs.' Joint ROGs and RFPs Download
May 11, 2022 2017 patent_own EX2017 - NOS of Plfs.' ROGs and RFPs (Joint) Download
Jun 7, 2022 2018 patent_own EX2018- 2022.01.21 [66] Mylan Letter to WV Clerk Download
Jun 7, 2022 2019 patent_own EX2019 - 2022.05.24 [72] STIPULATION and [Proposed] Order regarding claim construction Download
Jun 7, 2022 2020 patent_own EX2020 - 21-cv-00314 Docket Download
Jun 7, 2022 2021 patent_own EX2021 - 21-md-3017 Docket Download
Jun 7, 2022 2022 patent_own EX2022 - In Re_ Xarelto (Rivaroxaban) (21-3017) - DRL's Responses to Interrogatories Download
Sep 7, 2022 2023 patent_own Declaration of Alexander S. Zolan Download
Sep 7, 2022 2024 patent_own Declaration of Kathryn S. Kayali Download
Nov 15, 2022 2025 patent_own NCT01776424, ClinicalTrials.gov Download
Nov 15, 2022 2026 patent_own Trial Transcript, C.A. 1:14-264-RGA (D. Del.) (June 6, 2016) Download
Nov 15, 2022 2028 patent_own Curriculum Vitae of Dr. Jeffrey Weitz, M.D. Download
Nov 15, 2022 2029 patent_own Randall M. Zusman, M.D. Deposition Transcript, IPR2022-00517 (PTAB) (November 3, 2022) Download
Nov 15, 2022 2030 patent_own Weitz, Anticoagulation therapy in 2015: where we are and where we are going, J. Thromb. Thrombolysis 39:264-272 (2015) Download
Nov 15, 2022 2031 patent_own Jacomella et al., Novel anticoagulants in the therapy of peripheral arterial and coronary artery disease, Current Opinion in Pharmacology 13:294-300 (2013) Download
Nov 15, 2022 2032 patent_own Yeh et al., Overview of the New Oral Anticoagulants Opportunities and Challenges, Arterioscler Thromb. Vasc. Biol. 35:1056-1065 (2015) Download
Nov 15, 2022 2033 patent_own 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease, Circulation 135:e726-e779 (2017) Download
Nov 15, 2022 2034 patent_own Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary of Peripheral Artery Disease (COMPASS), NCT01776124, ClinicalTrials.gov (2013) JOINT_LDRIV0000368-71 Download
Nov 15, 2022 2035 patent_own Anand et al., Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomized, double-blind, placebo-controlled trial, Lancet 391:219-229 (2018) Download
Nov 15, 2022 2037 patent_own Download
Nov 15, 2022 2038 patent_own Reddy et al., The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes, J. od Cardiovascular Pharm. & Ther. 19(6):526-532 (2014) Download
Nov 15, 2022 2039 patent_own Download
Nov 15, 2022 2040 patent_own Download
Nov 15, 2022 2041 patent_own Download
Nov 15, 2022 2043 patent_own Fredenburgh et al., Emerging Anticoagulant Strategies, Blood 129(2):145-154 (2017) Download
Nov 15, 2022 2044 patent_own Chan et al., Evolving Treatment for Arterial and Venous Thrombosis Role of the Direct Oral Anticoagulants, Circulation Research 1409-1423 (2016) Download
Nov 15, 2022 2045 patent_own Weitz et al., Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014, Clinical Ther. 34(11):2506-2514e4 (2015) Download
Nov 15, 2022 2046 patent_own Caterina et al., Oral Anticoagulants in Coronary Heart Disease (Section IV), Thrombosis & Haemostasis 115:685-711 (2016) Download
Nov 15, 2022 2047 patent_own Weitz, Insights into the Role of Thrombin in the Pathogenesis of Recurrent Ischaemia After Acute Coronary Syndrome, Thrombosis & Haemostasis 112:924-931 (2014) Download
Nov 15, 2022 2048 patent_own Gradoli et al., Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study, Eut. Card. Review 13(2):115-118 (2018) Download
Nov 15, 2022 2049 patent_own Download
Nov 15, 2022 2050 patent_own Download
Nov 15, 2022 2051 patent_own FDA Letter re Meeting Preliminary Comments (December 12, 2018) (XARELTO310_00053946) Download
Nov 15, 2022 2052 patent_own FDA Letter re Meeting Minutes (December 18, 2018) (XARELTO310_00053947) Download
Nov 15, 2022 2053 patent_own Download
Nov 15, 2022 2054 patent_own FDA Letter re Information Request (March 22, 2019) (XARELTO310_00054231) Download
Nov 15, 2022 2055 patent_own FDA Letter re General Advice (May 3, 2019) (XARELTO310_00053952) Download
Nov 15, 2022 2056 patent_own Download
Nov 15, 2022 2057 patent_own Barnes, AHA/ACC Guidelines on the Management of Lower Extremity Peripheral Artery Disease, Amer. College of Cardiology (2016) Download
Nov 15, 2022 2060 patent_own Expert Declaration of Dr. Jeffrey Weitz, M.D. Download
Apr 4, 2023 2065 patent_own Randall M. Zusman, M.D. Deposition Transcript, IPR2022-00517 (PTAB) (March 17, 2023) Download
Mar 8, 2023 3001 board Ex. 3001 Download
Menu